Evidence map›Paper›PMID 32488651›Full record

ReviewGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2020

Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer.

K G P Kerckhoffs, D H W Liu, L Saragoni, R S van der Post, R Langer, M Bencivenga, M Iglesias, G Gallo, L C Hewitt, G E Fazzi and 10 more

Open access · hybridAbstract readReview
In one paragraph

Review in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  14. Article
  15. Review
  16. Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 8 countries.

K G P KerckhoffsDepartment of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands.
D H W LiuDepartment of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands.
L SaragoniPathology Unit, Morgagni-Pierantoni Hospital, Forlì, Italy.
R S van der PostDepartment of Pathology, Radboudumc, Nijmegen, The Netherlands.
R LangerInstitute of Pathology, University of Bern, Bern, Switzerland.
M BencivengaUnit of General and Upper GI Surgery , University of Verona, Verona, Italy.
M IglesiasPathology Department, Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain.
G GalloDepartment of Anatomic Pathology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
L C HewittDepartment of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands.
G E FazziDepartment of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands.
A M VosDepartment of Pathology, Radboudumc, Nijmegen, The Netherlands.
F RenaudDepartment of Pathology, Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR-S 1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
T YoshikawaDepartment of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
T OshimaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
A TomezzoliDepartment of Pathology, Verona University Hospital, Verona, Italy.
G de ManzoniUnit of General and Upper GI Surgery , University of Verona, Verona, Italy.
T AraiDepartment of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.ORCID 0000-0003-4583-8301
R KushimaDepartment of Pathology, Shiga University of Medical Science, Shiga, Japan.
F CarneiroInstitute of Molecular Pathology and Immunology at the University of Porto (Ipatimup), Porto, Portugal.
H I GrabschDepartment of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands. h.grabsch@maastrichtuniversity.nl.ORCID 0000-0001-9520-6228
Maastricht University · NLUniversity of Verona · ITRadboud University Nijmegen · NLAzienda Ospedaliero-Universitaria di Modena · ITCentre National de la Recherche Scientifique · FRKanagawa Prefectural Hospital Organization · JPOspedale G.B. Morgagni - L.Pierantoni · ITShiga University of Medical Science · JPTokyo Metropolitan Geriatric Hospital · JPTokyo National Hospital · JPUniversidade do Porto · PTUniversitat Autònoma de Barcelona · ESUniversity of Bern · CHUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe literature on the prognostic relevance of signet-ring cell (SRC) histology in gastric cancer (GC) is controversial which is most likely related to inconsistent SRC classification based on haematoxylin-eosin staining. We hypothesised that mucin stains can consistently identify SRC-GC and predict GC patient outcome.

methodsWe performed a comprehensive literature review on mucin stains in SRC-GC and characterised the mucin expression in 851 Caucasian GC and 410 Asian GC using Alcian Blue (AB)-Periodic Acid-Schiff (PAS), MUC2 (intestinal-type mucin), and MUC5AC (gastric-type mucin). The relationship between mucin expression and histological phenotype [poorly cohesive (PC) including proportion of SRCs, non-poorly cohesive (non-PC), or mucinous (MC)], clinicopathological variables, and patient outcome was analysed.

resultsDepending on mucin expression and cut-offs, the positivity rates of SRC-GC reported in the literature varied from 6 to 100%. Patients with MUC2 positive SRC-GC or SRC-GC with (gastro)intestinal phenotype had poorest outcome. In our cohort study, PC with ≥ 10% SRCs expressed more frequently MUC2, MUC5AC, and ABPAS (p < 0.001, p = 0.004 and p < 0.001, respectively). Caucasians with AB positive GC or combined ABPAS-MUC2 positive and MUC5AC negative had poorest outcome (all p = 0.002). This association was not seen in Asian patients.

conclusionsThis is the first study to suggest that mucin stains do not help to differentiate between SRC-GC and non-SRC-GC. However, mucin stains appear to be able to identify GC patients with different outcome. To our surprise, the relationship between outcome and mucin expression seems to differ between Caucasian and Asian GC patients which warrants further investigations.

Indexed as

AgedAsian PeopleCarcinoma, Signet Ring CellCohort StudiesCombined Modality TherapyEsophageal NeoplasmsFemaleHumansMaleMiddle AgedMucin-1PrognosisStomach NeoplasmsSurvival RateWhite PeopleMUC1 protein, humanMucin-1Gastric cancerHistological phenotypeMucinSignet-ring cellsSurvival

Identifiers

PMID32488651
PMCPMC7438382
OpenAlexW3029563037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.